• October Is Raynaud’s Awareness Month
  • Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments
  • Can Sacred Places Be Healing Spaces?
  • New US Patent Protects Corbus’ Scleroderma Therapy Until 2034
  • Raynaud’s Association Campaign Aims to Raise Awareness About Disease’s Pain
  • Faulty Filters and Omitted Opportunities in My Treatment Plan
  • Phase 1 Trial in Australia to Test Safety of Emerald’s Cannabidiol-based EHP-101  
  • BTX Improves Appearance of Scleroderma ‘En Coup De Sabre’ in 2 Patients, Study Shows
  • 50 Shades of Blue
  • Using a Timetable to Keep My Sanity During Scleroderma’s Changes
  • Cannabinoid-derived Therapies Slow Fibrosis, Block Inflammation in Scleroderma, Mouse Studies Show
  • #NORDSummit – More Than 700 Expected to Attend Oct. 15-16 Rare Disease Summit in Washington